Nordic Nanovector ASA (OSE: NANO), a Norway-based biopharmaceutical company, has named Malene Brondberg as its new CFO effective 1 May it was reported on Monday.

The new CFO was vice president Investor Relations and Corporation Communications. Brondberg joined Nordic Nanovector in February 2018 and has more than 20 years' operational experience in the financial services sector. Her career has included global head of Research managing a team of 67 people and member of the executive committee of the Nordic investment bank, ABG Sundal Collier. Since 2011, she has worked as a management consultant within the financial sector, acting as an advisor in investor relations and funding, and has held various interim CEO, COO and head of Compliance/HR/Finance management positions.

In the new role, Brondberg will be responsible for the areas of Finance, Human Resources and Investor Relations.